Home/Acepodia/Sonny Hsiao, Ph.D.

SH

Sonny Hsiao, Ph.D.

Chairman and CEO

Therapeutic Areas

Oncology Autoimmune Diseases

Acepodia Pipeline

Drug	Indication	Phase
ACE1831	Non-Hodgkin's Lymphoma	Phase I
ACE2016	EGFR-expressing Solid Tumors	Phase I
AD2C Program	Hepatocellular Carcinoma (targeting GPC3)	Preclinical

Leadership Team at Acepodia

Patrick Y. Yang, Ph.D.

Jennifer Wang, Ph.D.

Chief Technology Officer

Michael Kurman, M.D.

Head of Clinical Development

Carolyn Bertozzi, Ph.D.

Board of Directors, Chief Scientific Advisor

View full Acepodia profile